1. Effectiveness of fibroblast growth factor 23 lowering modalities in chronic kidney disease: a systematic review and meta-analysis
   Kullaya Takkavatakarn et al, 2022, International Urology and Nephrology CrossRef
2. Changes in Fibroblast Growth Factor 23 and Soluble Klotho Levels After Hemodialysis Initiation
   Chiaki Kawabata et al, 2020, Kidney Medicine CrossRef
3. The optimal timing of hemoperfusion component in combined hemodialysis–hemoperfusion treatment for uremic toxins removal
   Jiangtao Li et al, 2015, Renal Failure CrossRef
4. Effects of Convective Dialysis Techniques on Electrolytes and Mineral Metabolism
   Andrew Davenport et al, 2016, Hemodiafiltration CrossRef
5. Effect of blood purification on serum miR‐126 and VEGF levels in the process of atherosclerosis in uremic patients under maintenance hemodialysis
   Dong Zhao et al, 2018, The Kaohsiung Journal of Medical Sciences CrossRef
6. Clearance of FGF‐23 during continuous renal replacement therapy
   Shilpa Sharma et al, 2019, Hemodialysis International CrossRef
7. Differential expression of serum biomarkers in hemodialysis patients with mild cognitive decline: A prospective single-center cohort study
   Bin Zhu et al, 2018, Scientific Reports CrossRef